MapLight Therapeutics, Inc.
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q1 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | -18.5% | -24.6% | +205.8% | +86.4% | -12.7% | -12.0% | |
| – | – | – | – | – | -14.3% | -25.5% | +235.1% | +32.4% | +0.8% | -2.6% | |
| – | +550.0% | – | – | – | +31.1% | -33.3% | +91.7% | -27.2% | +19.2% | +28.6% | |
| – | +550.0% | – | – | – | -15.2% | -34.5% | +275.7% | +34.3% | +1.6% | -1.7% | |
| – | – | – | – | – | -14.5% | +9.6% | +16.5% | -10.8% | -10.3% | +5.8% | |
| – | – | – | – | – | -18.5% | +15.4% | +23.9% | -12.6% | -12.0% | +35.1% | |
| – | – | – | – | – | +3.5% | +3.5% | +3.5% | +3.4% | +3.3% | +33.9% | |
| – | – | – | – | – | -54.9% | +143.9% | +16.4% | +34.5% | -3.1% | -35.6% | |
| – | +728.1% | – | – | – | -19.3% | -31.4% | +266.2% | +96.3% | -12.8% | -12.9% | |
| – | – | – | – | – | – | – | – | – | – | – | |
| – | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +6.3% | +2.8% | +0.3% |
Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.